Rosavin exerts an antitumor role and inactivates the MAPK/ERK pathway in small-cell lung carcinoma in vitro

This study attempts to explore the function and mechanism of action of rosavin in small-cell lung cancer (SCLC) in vitro. The viability and clone formation of SCLC cells were assessed using cell counting kit-8 and colony formation assays, respectively. Apoptosis and cell cycle were detected using fl...

Full description

Saved in:
Bibliographic Details
Main Authors: Liu Rui, Jiang Cuihong, Zhao Zhizheng, Lv Yutong, Wang Gaoxing
Format: Article
Language:English
Published: Sciendo 2023-06-01
Series:Acta Pharmaceutica
Subjects:
Online Access:https://doi.org/10.2478/acph-2023-0015
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832570040305582080
author Liu Rui
Jiang Cuihong
Zhao Zhizheng
Lv Yutong
Wang Gaoxing
author_facet Liu Rui
Jiang Cuihong
Zhao Zhizheng
Lv Yutong
Wang Gaoxing
author_sort Liu Rui
collection DOAJ
description This study attempts to explore the function and mechanism of action of rosavin in small-cell lung cancer (SCLC) in vitro. The viability and clone formation of SCLC cells were assessed using cell counting kit-8 and colony formation assays, respectively. Apoptosis and cell cycle were detected using flow cytometry and cell cycle analysis, respectively. Wound healing and transwell assays were performed to evaluate the migration and invasion of SCLC cells. Besides, protein levels of p-ERK, ERK, p-MEK and MEK were determined using Western blot analysis. Rosavin repressed the viability and clone formation of SCLC cells, and promoted apoptosis and G0/G1 arrest of SCLC cells. At the same time, rosavin suppressed migration and invasion of SCLC cells. Moreover, protein levels of p-ERK/ERK and p-MEK/MEK were decreased after rosavin addition in SCLC cells. Rosavin impaired malignant behaviors of SCLC cells, which may be associated with inhibition of the MAPK/ERK pathway in vitro.
format Article
id doaj-art-f093bb67d19047b094b889e9ee136294
institution Kabale University
issn 1846-9558
language English
publishDate 2023-06-01
publisher Sciendo
record_format Article
series Acta Pharmaceutica
spelling doaj-art-f093bb67d19047b094b889e9ee1362942025-02-02T17:57:33ZengSciendoActa Pharmaceutica1846-95582023-06-0173226928010.2478/acph-2023-0015Rosavin exerts an antitumor role and inactivates the MAPK/ERK pathway in small-cell lung carcinoma in vitroLiu Rui0Jiang Cuihong1Zhao Zhizheng2Lv Yutong3Wang Gaoxing41Department of Oncology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences (South Campus)Beijing102618, China1Department of Oncology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences (South Campus)Beijing102618, China1Department of Oncology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences (South Campus)Beijing102618, China1Department of Oncology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences (South Campus)Beijing102618, China1Department of Oncology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences (South Campus)Beijing102618, ChinaThis study attempts to explore the function and mechanism of action of rosavin in small-cell lung cancer (SCLC) in vitro. The viability and clone formation of SCLC cells were assessed using cell counting kit-8 and colony formation assays, respectively. Apoptosis and cell cycle were detected using flow cytometry and cell cycle analysis, respectively. Wound healing and transwell assays were performed to evaluate the migration and invasion of SCLC cells. Besides, protein levels of p-ERK, ERK, p-MEK and MEK were determined using Western blot analysis. Rosavin repressed the viability and clone formation of SCLC cells, and promoted apoptosis and G0/G1 arrest of SCLC cells. At the same time, rosavin suppressed migration and invasion of SCLC cells. Moreover, protein levels of p-ERK/ERK and p-MEK/MEK were decreased after rosavin addition in SCLC cells. Rosavin impaired malignant behaviors of SCLC cells, which may be associated with inhibition of the MAPK/ERK pathway in vitro.https://doi.org/10.2478/acph-2023-0015small-cell lung cancerrosavinmekerk
spellingShingle Liu Rui
Jiang Cuihong
Zhao Zhizheng
Lv Yutong
Wang Gaoxing
Rosavin exerts an antitumor role and inactivates the MAPK/ERK pathway in small-cell lung carcinoma in vitro
Acta Pharmaceutica
small-cell lung cancer
rosavin
mek
erk
title Rosavin exerts an antitumor role and inactivates the MAPK/ERK pathway in small-cell lung carcinoma in vitro
title_full Rosavin exerts an antitumor role and inactivates the MAPK/ERK pathway in small-cell lung carcinoma in vitro
title_fullStr Rosavin exerts an antitumor role and inactivates the MAPK/ERK pathway in small-cell lung carcinoma in vitro
title_full_unstemmed Rosavin exerts an antitumor role and inactivates the MAPK/ERK pathway in small-cell lung carcinoma in vitro
title_short Rosavin exerts an antitumor role and inactivates the MAPK/ERK pathway in small-cell lung carcinoma in vitro
title_sort rosavin exerts an antitumor role and inactivates the mapk erk pathway in small cell lung carcinoma in vitro
topic small-cell lung cancer
rosavin
mek
erk
url https://doi.org/10.2478/acph-2023-0015
work_keys_str_mv AT liurui rosavinexertsanantitumorroleandinactivatesthemapkerkpathwayinsmallcelllungcarcinomainvitro
AT jiangcuihong rosavinexertsanantitumorroleandinactivatesthemapkerkpathwayinsmallcelllungcarcinomainvitro
AT zhaozhizheng rosavinexertsanantitumorroleandinactivatesthemapkerkpathwayinsmallcelllungcarcinomainvitro
AT lvyutong rosavinexertsanantitumorroleandinactivatesthemapkerkpathwayinsmallcelllungcarcinomainvitro
AT wanggaoxing rosavinexertsanantitumorroleandinactivatesthemapkerkpathwayinsmallcelllungcarcinomainvitro